Medicare Enrolled
Dr. Eric Wechsler, M.D.
Nephrology · Newport Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wechsler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wechsler?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wechsler
Dr. Eric Wechsler is a nephrology specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wechsler performed 2,222 Medicare services across 1,208 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wechsler received a total of $30,350 from 65 pharmaceutical and/or device companies across 621 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wechsler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in CA
$30,350 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,222
Medicare services
Top 25% in CA for nephrology
1,208
Unique beneficiaries
$114
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~117 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
872 | $105 | $338 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
506 | $83 | $253 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
273 | $94 | $235 |
| New patient office visit, complex (60-74 min) | 127 | $183 | $477 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
98 | $67 | $164 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
87 | $248 | $557 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
56 | $178 | $504 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
46 | $137 | $457 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
41 | $300 | $669 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $57 | $172 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
34 | $162 | $1,000 |
| Monthly dialysis physician visit A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment. |
25 | $169 | $425 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
16 | $137 | $1,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,350
Total received (2018-2024)
Avg $4,336/year across 7 years
Top 6% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
621
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,201 (60.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,149 (40.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,855
2023
$2,355
2022
$1,429
2021
$993
2020
$1,976
2019
$13,328
2018
$7,413
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$440
Novo Nordisk Inc
$255
Mallinckrodt Hospital Products Inc.
$239
Alexion Pharmaceuticals, Inc.
$231
Boehringer Ingelheim Pharmaceuticals, Inc.
$226
Amgen Inc.
$198
Otsuka America Pharmaceutical, Inc.
$195
Vifor Pharma, Inc.
$175
Bayer Healthcare Pharmaceuticals Inc.
$155
Novartis Pharmaceuticals Corporation
$146
CALLIDITAS THERAPEUTICS US INC.
$95
AstraZeneca Pharmaceuticals LP
$81
Ardelyx, Inc.
$80
Aurinia Pharma U.S., Inc.
$67
OPKO Pharmaceuticals, LLC
$62
Merck Sharp & Dohme LLC
$41
Lilly USA, LLC
$33
Recor Medical Inc
$26
Fresenius USA Marketing, Inc.
$24
Xeris Pharmaceuticals, Inc.
$24
Alnylam Pharmaceuticals Inc.
$24
Janssen Pharmaceuticals, Inc
$19
Exact Sciences Corporation
$18
Top 3 companies account for 32.7% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Therapeutics plc
$13,198
Fresenius USA Marketing, Inc.
$5,363
AstraZeneca Pharmaceuticals LP
$1,104
Otsuka America Pharmaceutical, Inc.
$1,023
Amgen Inc.
$966
Vifor Pharma, Inc.
$691
GlaxoSmithKline, LLC.
$629
OPKO Pharmaceuticals, LLC
$529
Relypsa, Inc.
$527
Alexion Pharmaceuticals, Inc.
$446
AKEBIA THERAPEUTICS INC
$427
GastroKlenz, Inc. DBA CloudCath
$400
Aurinia Pharma U.S., Inc.
$323
Novo Nordisk Inc
$296
Boehringer Ingelheim Pharmaceuticals, Inc.
$267
Mallinckrodt Hospital Products Inc.
$239
Amarin Pharma Inc.
$238
Novartis Pharmaceuticals Corporation
$232
Bayer Healthcare Pharmaceuticals Inc.
$225
Horizon Pharma plc
$215
ViiV Healthcare Company
$198
ARBOR PHARMACEUTICALS, INC.
$192
Keryx Biopharmaceuticals, Inc.
$174
Lundbeck LLC
$160
Bayer HealthCare Pharmaceuticals Inc.
$138
AbbVie Inc.
$131
Allergan Inc.
$125
Shire North American Group Inc
$117
CALLIDITAS THERAPEUTICS US INC.
$116
Daiichi Sankyo Inc.
$116
GENZYME CORPORATION
$102
Takeda Pharmaceuticals U.S.A., Inc.
$99
Calliditas Therapeutics US Inc.
$98
Alnylam Pharmaceuticals Inc.
$96
Genentech USA, Inc.
$83
AMAG Pharmaceuticals, Inc.
$82
Ardelyx, Inc.
$80
BAXTER HEALTHCARE
$71
Theratechnologies Inc.
$66
Travere Therapeutics, Inc.
$62
Merck Sharp & Dohme LLC
$62
Melinta Therapeutics, Inc.
$46
Exact Sciences Corporation
$40
Shionogi Inc
$39
Janssen Biotech, Inc.
$39
Janssen Pharmaceuticals, Inc
$36
Merck Sharp & Dohme Corporation
$35
Shield Therapeutics Inc
$34
Veloxis Pharmaceuticals, Inc.
$34
EMD Serono, Inc.
$34
Lilly USA, LLC
$33
Gilead Sciences, Inc.
$32
Recor Medical Inc
$26
NxStage Medical, Inc.
$25
Mallinckrodt Enterprises LLC
$25
Xeris Pharmaceuticals, Inc.
$24
Ultragenyx Pharmaceutical Inc.
$20
SANOFI-AVENTIS U.S. LLC
$17
Philips Electronics North America Corporation
$17
Arbor Pharmaceuticals, Inc.
$16
PFIZER INC.
$16
Mission Pharmacal Company
$14
Theravance Biopharma, Inc.
$14
BTG International, Inc.
$14
La Jolla Pharmaceutical Company
$13
Top 3 companies account for 64.8% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AURYXIA · AVYCAZ · Aranesp · Auryxia · BENLYSTA · BRILINTA · BYSTOLIC · CRYSVITA · Cologuard Collection Kit · Critline - Monitors · DALVANCE · DOVATO · DUEXIS · EGRIFTA · ENTRESTO · Edarbi · Envarsus XR (SP) · FABRAZYME · FABRY-DISEASE · FARXIGA · FERAHEME · Fetroja · GATTEX · GIAPREZA · IBSRELA · INJECTAFER · INVOKANA · ISENTRESS · JARDIANCE · JULUCA · JYNARQUE · KEVEYIS · KRYSTEXXA · Kerendia · LINZESS · LOKELMA · LUPKYNIS · MOUNJARO · NORTHERA · Not Product Related · ONPATTRO · OXLUMO · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PIFELTRO · PRALUENT · PREZCOBIX · Parsabiv · Prolia · RAYALDEE · RETACRIT · RUKOBIA · Rayaldee · Renal - CRRT · Renal - PD · Respiratoriy Care Undiv · Rituxan · SAMSCA · SEROSTIM · SOLIRIS · Strensiq · System One · TARPEYO · TAVNEOS · TEFLARO · TRIUMEQ · Tavneos · Trintellix · ULTOMIRIS · Uloric · Urocit-K · VERQUVO · VIBATIV · VORAXAZE · Vabomere · Vascepa · Velphoro · Veltassa · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for nephrology in CA.
Geographic Context
Nephrologists within 10 mi
145
Per 100K population
4.6
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wechsler is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wechsler experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Wechsler performed 872 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wechsler receive payments from pharmaceutical companies?
Yes. Dr. Wechsler received a total of $30,350 from 65 companies across 621 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wechsler's costs compare to other nephrologists in Newport Beach?
Dr. Wechsler's average Medicare payment per service is $114. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wechsler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Newport Beach
Browse nephrologists in Newport Beach ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in CA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in CA
Which CA nephrologists receive the most from drug and device companies.
By company
Horizon Therapeutics plc Payments to Doctors
See all physicians who received payments from Horizon Therapeutics plc.
By company
Fresenius USA Marketing, Inc. Payments to Doctors
See all physicians who received payments from Fresenius USA Marketing, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology